References
1. Jacobs MF, Anderson B, Opipari VP, Mody R. Hepatosplenic αβ T-Cell
Lymphoma as Second Malignancy in Young Adult Patient With Previously
Undiagnosed Ataxia-Telangiectasia. Journal of Pediatric
Hematology/Oncology. 2020.
2. Shenhod E, Benzeev B, Sarouk I, Heimer G, Nissenkorn A. Functional
parameter measurements in children with ataxia telangiectasia.
Developmental Medicine & Child Neurology. 2020;62(2):207-13.
3. Mathew MG. Management of a pediatric patient with ataxia
telangiectasia: Report of a rare case in which diagnostic radiographs
are contraindicated. Journal of Family Medicine and Primary Care.
2020;9(2):1199.
4. Perlman S. Functionally meaningful rating scales in progressive
pediatric movement disorders. Wiley Online Library; 2020.
5. Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari
S-R, et al. Ataxia-telangiectasia in Iran: clinical and laboratory
features of 104 patients. Pediatric neurology. 2007;37(1):21-8.
6. Amirifar P, Mozdarani H, Yazdani R, Kiaei F, Moeini Shad T,
Shahkarami S, et al. Effect of Class Switch Recombination Defect on the
Phenotype of Ataxia-Telangiectasia Patients. Immunological
Investigations. 2020:1-15.
7. Xu P, Sun Y, Song Y, Jiao J, Shen B, Li W, et al. ATM kinase
regulates tumor immunoreactions in lymphocyte-predominant breast cancer
through modulation of NKG2D ligand and TNF cytokines on tumor cells.
Medical Molecular Morphology. 2020:1-11.
8. Tatfi M, Hermine O, Suarez F. Epstein-Barr Virus (EBV)-Related
Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM
Regulate EBV Life Cycle? Frontiers in immunology. 2019;9:3060.
9. Sarkar A, Stellrecht CM, Vangapandu HV, Ayres M, Kaipparettu BA, Park
JH, et al. Ataxia telangiectasia mutated interacts with Parkin and
induces mitophagy independent of kinase activity. Evidence from mantle
cell lymphoma. Haematologica. 2020.
10. Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari
SR, et al. Ataxia-telangiectasia in Iran: clinical and laboratory
features of 104 patients. Pediatr Neurol. 2007 Jul;37(1):21-8.
11. Zaki-Dizaji M, Tajdini M, Kiaee F, Shojaaldini H, Badv RS,
Abolhassani H, et al. Dystonia in Ataxia Telangiectasia: A Case Report
with Novel Mutations. Oman Medical Journal. 2020;35(1):e93.
12. Langhagen T, Blaschek A, Rettinger N, Müller-Felber W, Jahn K. Case
report: oculomotor apraxia in ataxia telangiectasia. Neuropediatrics.
2013;44(02):VS12-02.
13. Alyasin S, Esmaeilzadeh H, Ebrahimi N, Nabavizadeh SH, Nemati H.
Clinical Presentation of Ataxia-Telangiectasia. Archives of Iranian
Medicine (AIM). 2019;22(12).
14. Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA,
Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet
journal of rare diseases. 2016;11(1):159.
15. Yang Y, Herrup K. Loss of neuronal cell cycle control in
ataxia-telangiectasia: a unified disease mechanism. Journal of
Neuroscience. 2005;25(10):2522-9.
16. Chenevix-Trench G, Spurdle A, Terry MB, Daly M, Buys S, Southey M,
et al. Rare variants in the ATM gene and risk of breast cancer. 2011.